Close
American Drug Delivery & Formulation Summit

ChargePoint Technology and Famat Sampling partner up to create robust containment solution for HPAPI powder transfer

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Related stories

TRT Safety: What Current Research Actually Says About Long-Term Use

Testosterone replacement therapy has spent years caught between two...

Merck Signs Voluntary Licensing Deals for Oral HIV Pill

Merck has entered into seven voluntary licensing agreements with...

Trump Proposes Generic Drug Tariffs to Drive Reshoring Effort

President Donald Trump announced plans to implement massive generic...
- Advertisement -

Powder transfer specialist, ChargePoint Technology has joined forces with sampling device specialist, Famat Sampling, to tackle one of the industryโ€™s most challenging containment problems. The pharmaceutical suppliers have created an integrated valve solution capable of allowing operators to take a product sample during the course of the production process for quality analysis while maintaining optimum containment and sterile integrity.ย 

The powerful combination of ChargePoint Technologyโ€™s split butterfly valve and Famat Samplingโ€™s 125-TC/OEL valve creates a secure and sterile environment for high- potency and sterile powder samples to be taken. The interconnected system forms an airtight seal that prevents a dead zone and allows samples of highly potent, toxic or sterile powders to be transferred into containers safely and securely, maintaining OEB4 and OEB5 level compliance.ย 

The integrated network of valves allow for rigorous testing capabilities and ensure that product quality is maintained during the process and it is FDA compliant. The combination of products help minimise risk to the operator, who could be exposed to potentially dangerous powders during the sampling process.ย 

The powder product must not be altered during sampling, as oxygen or other particles could come into contact during the extraction process and damage the product. The combination of technologies from ChargePoint Technology and Famat acts as an isolator and offers users a safe method of transfer so the quality of the product can be protected.ย 

Christian Dunne, Head of Sterile Solutions at ChargePoint Technology, commented on the partnership: โ€œThe HPAPI market is predicted to grow by 8.7%ย  to reach a value of $34.97 billion by 2028 (1), highlighting why itโ€™s vital for drug manufacturers to invest in appropriate containment technologies, as while ensuring they are able to maintain optimum product quality.ย 

โ€œDuring processing, manufacturers must prioritise sampling so that the quality of drug products can be assessed at various stages of the production process. Famat Sampling shares our high standards for quality. Joining forces as two recognised industry leaders in our respective fields was a no-brainer for our team.ย 

โ€œOur shared depth and breadth of knowledge and experience have allowed us to create a solution that helps solve a prevalent issue for manufacturers and adds additional protection for users.โ€ย 

ChargePoint Technology offers containment and aseptic transfer valves and single-use solutions that are essential for the safe transfer of powders during pharmaceutical and biopharmaceutical manufacturing.

Never miss a pharmaceutical headline

The pharmaceutical industry moves fast โ€“ stay on top of it with our must - read briefings.

  • The top pharma and life sciences stories, straight to your inbox
  • The biggest news, features, interviews, and analysis
  • Dedicated coverage of the key developments driving the global pharmaceutical sector

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access the Media Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Latest stories

Related stories

TRT Safety: What Current Research Actually Says About Long-Term Use

Testosterone replacement therapy has spent years caught between two...

Merck Signs Voluntary Licensing Deals for Oral HIV Pill

Merck has entered into seven voluntary licensing agreements with...

Trump Proposes Generic Drug Tariffs to Drive Reshoring Effort

President Donald Trump announced plans to implement massive generic...

Polymer Science Advancing Sustained Drug Delivery

The development of sustained-release drug delivery systems has transformed...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

โ€“ Access theMedia Pack Now

โ€“ Book a Conference Call

โ€“ Leave Message for Us to Get Back

Translate ยป